Total Funding
62
47
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
241504
Evolutionary Genomics is a research company that is focused on identification and validation of genes.
Past Role: Bacterin International Holdings, Chief Financial Officer/Board Member- Walter Messier: Chief Science Officer
About the Company
Evolutionary Genomics (EG) is a unique biotechnology company that is changing how relevant gene/target discovery and validation is performed during the post-genomics era. The company's proprietary Adapted Traits platform sifts through vast amounts of genomic data to identify only those genes that have a high likelihood of commercial
value for downstream validation.
EG applies this platform to identify high-value targets for drug-discovery or genes for use in natural crop yield or pest/disease-resistance enhancement.
Women Founded
